Continuous Administration of a Monophasic Oral Contraceptive in the Treatment of Primary Dysmenorrhea.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ethinylestradiol/gestodene (Primary)
- Indications Dysmenorrhoea
- Focus Therapeutic Use
- 28 Apr 2017 Biomarkers information updated
- 19 Oct 2011 Results presented at the 67th Annual Meeting of the American Society for Reproductive Medicine.
- 26 Sep 2011 Planned end date changed from 1 Jun 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.